/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. AI For Pharma Growth
  2. E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection
E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection

AI For Pharma Growth · Apr 28, 2026

AI Site Twins are revolutionizing clinical trial site selection, replacing outdated methods with a data-driven approach to cut timelines & costs.

Right.AI Infers Clinical Site Quality Using Sponsor Re-Selection as a Performance Proxy

Instead of relying on often unavailable direct enrollment data, the AI system identifies sites repeatedly chosen by the same sponsor for similar trials. This pattern serves as a powerful, indirect indicator of successful past performance and high-quality operations, offering a more nuanced view than simply counting patients.

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection thumbnail

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection

AI For Pharma Growth·4 months ago

Reliance on Existing Relationships Causes 80% of Clinical Trial Sites to Underperform

The industry's standard practice of selecting sites based on pre-existing relationships and convenience—the "easy button"—is a primary driver of failure. This leads to 80% of activated sites missing enrollment targets and 30% enrolling zero patients, a massive, systemic inefficiency that data-driven approaches can solve.

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection thumbnail

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection

AI For Pharma Growth·4 months ago

Right.AI's Universal "Site Twin" Model Disrupts the Traditional Closed-Network Approach

Most tech vendors offer data only on sites within their proprietary network. Right.AI upended this by creating a digital twin for every research site globally, regardless of affiliation. This provides a comprehensive, unbiased view of the entire landscape, eliminating the limitations and blind spots of closed ecosystems.

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection thumbnail

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection

AI For Pharma Growth·4 months ago

A Free Search Tool, writesites.com, Creates a Powerful Data Flywheel for Right.AI

By offering a free search engine for sponsors, Right.AI captures valuable engagement data. Every search and interaction enriches the underlying "AI Site Twins," making the core platform more powerful. This creates a self-reinforcing loop where free usage by one side of the market enhances the paid product for the other.

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection thumbnail

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection

AI For Pharma Growth·4 months ago

Right.AI Uses a Multi-Agent AI System to Dynamically Enrich Its "Site Twins"

The platform uses specialized AI agents for different tasks: "retriever" agents pull public data, a "Snoopy" agent actively seeks missing information, and interaction agents analyze communications to extract context. This multi-agent architecture continuously and automatically improves data granularity for every site in its global database.

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection thumbnail

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection

AI For Pharma Growth·4 months ago

Pharma Leaders Should Adopt AI Strategically, Not Through Hesitant, Isolated Pilots

To truly benefit from transformative AI, leaders are advised against running small, tactical pilots. Instead, they should develop a clear strategy, make a decisive commitment to a platform, and integrate it as a core strategic initiative. This approach avoids incrementalism and achieves significant results much faster.

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection thumbnail

E215: Location, Location, Innovation: AI Site Twins and the New Era of Site Selection

AI For Pharma Growth·4 months ago